Mahmoud Rafea

Mahmoud Rafea is a prominent figure in the field of medical research and development, particularly in the area of tuberculosis (TB) diagnostics. Here's what we know about him:

Professional Background

Mahmoud Rafea holds multiple key positions at Erythra Inc.:

• Chief Executive Officer (CEO)13
• Chief Scientist3

He has been serving in these roles since 2018.3 Erythra is a company focused on developing medical products based on the discovery of Erythrocytes Dynamic Antigens Store (EDAS).1

Academic and Research Experience

• Education: Dr. Rafea holds a Ph.D. in Computer Science with a focus on Artificial Intelligence from Cairo University, which he obtained in 1995.5
• Academic Position: He is a Professor Emeritus and has served as the Executive Director of Erythrocytes Dynamic Antigens Store (EDAS) since 2014.3
• Research Focus: His work primarily involves developing medical products based on the newly discovered EDAS technology.2

Contributions to TB Research

Under Dr. Rafea's leadership, Erythra has made significant strides in TB diagnostics:

• The company has developed a comprehensive test for diagnosis and treatment monitoring of TB patients.1
• Erythra's TB test aims to facilitate early diagnosis and detection of cure, potentially reducing the risk of TB transmission in communities.1

Professional Experience

Prior to his current roles, Dr. Rafea has had a diverse career:

• He built and ran a successful private clinical pathology laboratory.4
• He practiced as a laboratory pathologist for 20 years.4
• He spent two years as a senior researcher in Stockholm, Sweden, during a sabbatical.5

Dr. Mahmoud Rafea's work at Erythra combines his expertise in artificial intelligence, pathology, and medical research to advance the field of TB diagnostics and potentially other medical applications based on EDAS technology.